Spain – Pharmaceutical products – Suministro de SELUMETINIB (KOSELUGO) de distribución exclusiva., con destino al servicio de Farmacia Hospital Clínico San Carlos
awardedHOSPITAL CLINICO SAN CARLOS DE MADRID · Q2877008I
Description
SELUMETINIB (KOSELUGO 10 MG CAPSULA)
Key facts
- Procedure
- neg-wo-call
- Regime
- publicSector
- Contract references
- PNSP 2026-1-344
- Category
- supplies
Awarded suppliers
- Alexion Pharma Spain, S.L.U. · B64494784 · ES511, ES
Supplier location as published: Barcelona, ES511, 08029, ES
Ground given for limiting competition
The buyer’s own stated reason for awarding without open competition, as published. Their assertion, not a finding.
exclusive
Proveedor exclusivo, artículo 168 párrafo 2.º de la Ley 9/2017, de 8 de noviembre, de Contratos del Sector Público, por la que se transponen al ordenamiento jurídico español las Directivas del Parlamento Europeo y del Consejo 2014/23/UE y 2014/24/UE, de 26.2.2014, requiere la no existencia de competencia por razones técnicas y la protección de derechos exclusivos, incluidos los derechos de propiedad intelectual e industrial se aplicará cuando no exista una alternativa o sustitución razonable.
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 772301-2026
- First seen
- 6 Nov 2026
- Last updated
- 6 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
GET /api/v1/tenders/34dd3340-45cb-47c7-8e1b-cb2eb53260ddThe source notice is authoritative — verify deadlines and documents there before bidding.